2020
Hospital Microbiologic Culture Results to Predict the Use of Anti–methicillin-Resistant Staphylococcus aureus (MRSA)
Wu H, Kratzer T, Zhou L, Soe M, Edwards J, Neuhauser M, Benin A, Hicks L, Srinivasan A, Pollock D. Hospital Microbiologic Culture Results to Predict the Use of Anti–methicillin-Resistant Staphylococcus aureus (MRSA). Infection Control And Hospital Epidemiology 2020, 41: s40-s40. DOI: 10.1017/ice.2020.521.Peer-Reviewed Original ResearchAnti-MRSA agentsNational Healthcare Safety NetworkPositive infectionsMicrobiologic culture resultsInfection burdenAntimicrobial useHospital characteristicsCulture resultsStandardized antimicrobial administration ratioStaphylococcus aureusRisk adjustmentLower respiratory specimensIntensive care unitAcute care hospitalsQuinupristin/dalfopristinResistant Staphylococcus aureusMedical school affiliationAU ratesIntravenous vancomycinMicrobiologic dataCare unitDay patientsRespiratory specimensAntimicrobial daysHigh prevalence
2019
Antimicrobial therapy for asymptomatic bacteriuria or candiduria in advanced cancer patients transitioning to comfort measures
Datta R, Wang T, Zhu M, Dembry LM, Han L, Allore H, Quagliarello V, Juthani-Mehta M. Antimicrobial therapy for asymptomatic bacteriuria or candiduria in advanced cancer patients transitioning to comfort measures. Infection Control And Hospital Epidemiology 2019, 40: 470-472. PMID: 30821230, PMCID: PMC6482377, DOI: 10.1017/ice.2019.22.Peer-Reviewed Original ResearchConceptsUrinary tract infectionIncidence rate ratiosAdvanced cancer patientsAsymptomatic bacteriuriaCancer patientsAntimicrobial therapySymptomatic urinary tract infectionPotential urinary tract infectionTract infectionsInappropriate therapyAntimicrobial daysComfort measuresBacteriuriaCandiduriaCFU/mLPatientsTherapyRate ratioMLInfection
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply